An In Situ Forming Hydrogel for Orthopedic Care
OsteoFill Gel™ is a thermoresponsive injectable hydrogel designed for bone void filling and infection management — with a versatile carrier platform extending into pain management, regenerative medicine, and oncology.
OsteoFill™ Gel Platform
A single thermoresponsive hydrogel platform addressing bone void filling, local infection management, and sustained drug delivery.
OsteoFill™ Gel mechanism of action — thermoresponsive gelation and sustained drug release
OsteoFill™ Gel
Injectable thermoresponsive hydrogel — bone void filler with antibiotic delivery capability.
- Injectable and minimally invasive
- Sustained local drug delivery
- Temperature-responsive in situ gelation
- Biodegradable over approximately 60 days
- Osteoconductive scaffold for bone regeneration
- Compatible with multiple therapeutic agents
Pipeline Indications
Bone Void Filling
Osteoconductive scaffold
Fills irregular bone defects conformally, leaving no gap for infection.
Local Infection Management
Vancomycin / Tobramycin
Sustained local antibiotic delivery for osteomyelitis and periprosthetic infection.
Pain Management
Future generation
OsteoFill™ Plus — post-surgical pain management (future platform generation).
Oncology Delivery
Future generation
OsteoFill™ Guard — solid tumor applications (future platform generation).
We welcome clinical, academic, investment, and distribution partnerships to accelerate translation of OsteoFill™ Gel from bench to bedside.